Musli Thyropeutics Ltd.
🇮🇱Israel
- Country
- 🇮🇱Israel
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.musli.co.il
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Study of Induction of Hypothyroxinemia Adjunct to Conventional Therapies in GBM Patients
Phase 2
Terminated
- Conditions
- Glioblastoma Multiforme (GBM)
- Interventions
- Drug: Combined T3 and Methimazole treatment
- First Posted Date
- 2016-01-13
- Last Posted Date
- 2018-03-22
- Lead Sponsor
- Musli Thyropeutics Ltd.
- Target Recruit Count
- 3
- Registration Number
- NCT02654041
- Locations
- 🇮🇱
Tel-Aviv Medical Center, Israel, Tel-Aviv, Israel
News
No news found